Xenios looks back on a very successful ESICM 2016 congress October 1-5 in Milano, Italy. Extracorporeal CO2 removal was a main topic during the scientific lectures where the outstanding potential of this therapy to prevent ventilator-induced lung damage was discussed. On the booth we presented the Novalung therapy (interventional lung assist, iLA) and our UNIQUE XENIOS PLATFORM. Many visitors followed the live presentations of our new information and education tool XENIOS CAMPUS providing videos, webinars and a lot more supportive material for implementing and applying Xenios lung and heart therapies.
